Whitehawk Therapeutics/$WHWK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Whitehawk Therapeutics
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
Ticker
$WHWK
Sector
Primary listing
Employees
29
Headquarters
Website
WHWK Metrics
BasicAdvanced
$201m
-
-$1.67
0.77
-
Price and volume
Market cap
$201m
Beta
0.77
52-week high
$5.50
52-week low
$1.57
Average daily volume
408k
Financial strength
Current ratio
11.356
Quick ratio
11.129
Profitability
EBITDA (TTM)
-122.681
Management effectiveness
Return on assets (TTM)
-42.46%
Return on equity (TTM)
-68.54%
Valuation
Price to book
1.65
Price to tangible book (TTM)
1.65
Price to free cash flow (TTM)
-2.61
Free cash flow yield (TTM)
-38.31%
Free cash flow per share (TTM)
-1.556
Growth
Revenue change (TTM)
-100.00%
Earnings per share change (TTM)
-282.80%
3-year earnings per share growth (CAGR)
-13.45%
What the Analysts think about WHWK
Analyst ratings (Buy, Hold, Sell) for Whitehawk Therapeutics stock.
WHWK Financial Performance
Revenues and expenses
WHWK Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs